Transcriptomic Study of IBD-associated Colorectal Cancer
Transcriptiomic Analysis of Inflammatory Bowel Disease-associated Colorectal Cancer. A French Retrospective Study of 26 Cases Identified at the Nancy University Hospital
1 other identifier
observational
26
0 countries
N/A
Brief Summary
Chronic inflammatory bowel disease (IBD) is associated with an increased risk of colorectal cancer (CRC) in historical cohorts. The pathways of oncogenesis of these CRCs, which are very different clinically from de novo CRCs, are currently unknown. The aim of our work is to identify specific molecular signatures of CRC occurring in the setting of IBD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2010
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2021
CompletedFirst Submitted
Initial submission to the registry
September 19, 2021
CompletedFirst Posted
Study publicly available on registry
September 29, 2021
CompletedOctober 7, 2021
September 1, 2021
11 years
September 19, 2021
September 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
IBD associated CRC oncogenesis
Percentage of gene expression variation in CRC tumor tissue samples in the following groups patients with CRC and IBD
1 year
Interventions
transcriptomic analysis on preserved tumor tissue
Eligibility Criteria
\>/= 18 years old patient operated on at the Nancy university hospital for IBD associated CRC
You may qualify if:
- Person 18 years of age or older
- Person with colorectal cancer in the context of IBD
- Person who has received complete information on the organization of the research and who has signed an informed consent
- Person affiliated to a social security plan or beneficiary of such a plan.
You may not qualify if:
- Person referred to in articles L. 1121-5, L. 1121-7 and L1121-8 of the public health code:
- Pregnant woman, parturient or nursing mother
- Minor (not emancipated)
- Adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice)
- Person of legal age who is unable to express his or her consent
- Person deprived of liberty by a judicial or administrative decision, persons subject to psychiatric care under articles L. 3212-1 and L. 3213-1.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor (MD, PhD Student), Principal investigator
Study Record Dates
First Submitted
September 19, 2021
First Posted
September 29, 2021
Study Start
January 1, 2010
Primary Completion
January 1, 2021
Study Completion
January 1, 2021
Last Updated
October 7, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share